Phase II and Pharmacokinetic Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) in Patients With Advanced Colorectal Cancer Who Have Failed Previous 5-FU Based Chemotherapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2008
At a glance
- Drugs Rubitecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 10 Sep 2005 New trial record.